BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3379072)

  • 1. Platelet-activating factor induces glycogen degradation in fetal rabbit lung in utero.
    Hoffman DR; White RG; Angle MJ; Maki N; Johnston JM
    J Biol Chem; 1988 Jul; 263(19):9316-9. PubMed ID: 3379072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of platelet-activating factor on glycogen metabolism in fetal rat lung.
    Bourbon JR; Hoffman DR; Johnston JM
    Exp Lung Res; 1991; 17(4):789-801. PubMed ID: 1935836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and function of platelet-activating factor in fetal rabbit lung development.
    Hoffman DR; Truong CT; Johnston JM
    Biochim Biophys Acta; 1986 Oct; 879(1):88-96. PubMed ID: 3768390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of platelet activating factor by cholinephosphotransferase in developing fetal rabbit lung.
    Hoffman DR; Bateman MK; Johnston JM
    Lipids; 1988 Feb; 23(2):96-100. PubMed ID: 2897059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of platelet-activating factor in human fetal lung maturation.
    Hoffman DR; Truong CT; Johnston JM
    Am J Obstet Gynecol; 1986 Jul; 155(1):70-5. PubMed ID: 3728606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAF increases hepatic vascular resistance and glycogenolysis in vivo.
    Hines KL; Braillon A; Fisher RA
    Am J Physiol; 1991 Mar; 260(3 Pt 1):G471-80. PubMed ID: 1848410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of rabbit fetal glycogen: effect of in utero fetal decapitation on the metabolism of glycogen in fetal heart, lung, and liver.
    Bhavnani BR; Woolever CA; Pan CC
    Biochem Cell Biol; 1986 May; 64(5):405-12. PubMed ID: 3718709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the synthesis of platelet-activating factor and its inactive storage precursor (1-alkyl-2-acyl-sn-glycero-3-phosphocholine) from 1-alkyl-2-acetyl-sn-glycerol by rabbit platelets.
    Lee TC; Malone B; Blank ML; Fitzgerald V; Snyder F
    J Biol Chem; 1990 Jun; 265(16):9181-7. PubMed ID: 2160964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
    Salari H; Dryden P; Howard S; Bittman R
    Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of platelet-activating factor in rats in vivo. Stimulation of hepatic glycogenolysis and lipogenesis.
    Evans RD; Ilic V; Williamson DH
    Biochem J; 1990 Jul; 269(1):269-72. PubMed ID: 2165397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils.
    Doebber TW; Wu MS
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7557-61. PubMed ID: 3478712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrylyl-PAF, a synthetic platelet-activating factor analogue.
    Duffy-Krywicki RH; Steinhelper ME; Olson MS
    J Lipid Mediat; 1991; 3(3):345-59. PubMed ID: 1773032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia attenuates metabolism of platelet activating factor by fetal and newborn lamb lungs.
    Salva AM; Ibe BO; Cliborn E; Reyes G; Raj JU
    J Lipid Res; 1996 Apr; 37(4):783-9. PubMed ID: 8732778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M; Coƫffier E; Polonsky J; Benveniste J
    Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit blastocysts accumulate platelet-activating factor (PAF) and lyso-PAF in vitro.
    Jones MA; Kudolo GB; Harper MJ
    Mol Reprod Dev; 1992 Jul; 32(3):243-50. PubMed ID: 1323306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet activating factor on histamine and leukotriene C4 release from human leukocytes.
    Columbo M; Horowitz EM; Patella V; Kagey-Sobotka A; Chilton FH; Lichtenstein LM
    J Allergy Clin Immunol; 1993 Aug; 92(2):325-33. PubMed ID: 7688778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
    Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding sites for platelet activating factor in human lung tissues.
    Hwang SB; Lam MH; Shen TY
    Biochem Biophys Res Commun; 1985 Apr; 128(2):972-9. PubMed ID: 2986633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla.
    Kawasaki T; Snyder F
    Biochim Biophys Acta; 1987 Jul; 920(1):85-93. PubMed ID: 3036238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.